Literature DB >> 10064257

The role of Citrobacter in clinical disease of children: review.

T I Doran1.   

Abstract

Various species of Citrobacter may cause infections in neonates and immunocompromised hosts. Citrobacter koseri (formerly Citrobacter diversus) is best known as the cause of sepsis and meningitis leading to central nervous system (CNS) abscesses in neonates and young infants. Early onset and late-onset infections occur as for other neonatal bacterial infections. The majority of cases are sporadic, with no clear source of infection. A few have been confirmed to be vertically transmitted, and nosocomial outbreaks have occurred in neonatal care units. The pathophysiology is not well understood, but a surface protein has been identified as a possible virulence factor among strains that cause citrobacter brain abscesses in neonates. Despite improvements in diagnostic imaging techniques, surgery, and antibiotic therapy, approximately one-third of infants with abscesses die, and one-half sustain CNS damage. In this article, the taxonomy, epidemiology, pathogenesis, diagnosis, treatment, and outcome of citrobacter disease in children are reviewed.

Entities:  

Mesh:

Year:  1999        PMID: 10064257     DOI: 10.1086/515106

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  48 in total

1.  Sepsis, meningitis and cerebral abscesses caused by Citrobacter koseri.

Authors:  Clara Vaz Marecos; Marta Ferreira; Maria Manuela Ferreira; Maria Rosalina Barroso
Journal:  BMJ Case Rep       Date:  2012-01-23

2.  An infant with orange-colored urine.

Authors:  Serwet Demirdas; Cornelis H Schröder
Journal:  Pediatr Nephrol       Date:  2009-10-21       Impact factor: 3.714

3.  Citrobacter koseri folliculitis of the face.

Authors:  D D Raia; M Barbareschi; S Veraldi
Journal:  Infection       Date:  2015-01-29       Impact factor: 3.553

Review 4.  Musculoskeletal infections associated with Citrobacter koseri.

Authors:  T A Kwaees; Z Hakim; C Weerasinghe; P Dunkow
Journal:  Ann R Coll Surg Engl       Date:  2016-07-14       Impact factor: 1.891

5.  Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii.

Authors:  Thierry Naas; Daniel Aubert; Ayla Ozcan; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2007-01-22       Impact factor: 5.191

6.  Citrobacter koseri causing osteomyelitis in a diabetic foot with concomitant acute gouty arthritis successfully treated with ertapenem.

Authors:  Dillon Tinevez; Nebojsa Nick Knezevic
Journal:  BMJ Case Rep       Date:  2019-07-27

Review 7.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

8.  Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patients.

Authors:  Peter W Kim; Anthony D Harris; Mary-Claire Roghmann; J Glenn Morris; Arjun Strinivasan; Eli N Perencevich
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

9.  Citrobacter koseri brain abscess in the neonatal rat: survival and replication within human and rat macrophages.

Authors:  Stacy M Townsend; Harvey A Pollack; Ignacio Gonzalez-Gomez; Hiroyuki Shimada; Julie L Badger
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Citrobacter infections in a general hospital: characteristics and outcomes.

Authors:  G Samonis; D E Karageorgopoulos; D P Kofteridis; D K Matthaiou; V Sidiropoulou; S Maraki; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.